Mediware's New Chemotherapy Software Realizes Early International Success
LENEXA, Kan., Aug. 15, 2012 (GLOBE NEWSWIRE) -- Mediware Information Systems, Inc. (Nasdaq:MEDW) today announced that the company's new chemotherapy management software has realized early success through the addition of two new contracts with prestigious hospitals in the Netherlands. The new customers include St. Antonius Hospital in Nieuwegein, and Catherina Hospital in Eindhoven. Mediware announced the acquisition of this software on April 18, 2012 from Cobbler ICT Services BV and is currently marketing the software in the Netherlands and Belgium. Mediware is also aggressively building interest for the product in the United Kingdom where the company's JAC subsidiary has a significant customer base using its medication management suite of products.
The agreement with St. Antonius represents the largest sale to date for the chemotherapy management software. The hospital, which licensed the software in July, is implementing advanced automation programs for the treatment of cancer at the 700 bed teaching facility. They plan to use the software to automate and support the data management needs for the entire care process, from electronic ordering (CPOE) to preparation and administration of the specialty drug inventories. The Mediware system also includes an integrated electronic patient record to enable doctors and nurses to monitor treatments and patient outcomes over time, as well as the ability to integrate with other key information systems to help manage these complex therapies. The contract with Catherina Hospital was completed in May.
"Oncology is one of the fastest growing areas of healthcare technology because of the extreme complexity of patient cases and an intense need for both safety and efficiency," said Thomas Mann, Mediware's president and chief executive officer. "This is an excellent example of where technology, and specifically information systems, can improve caregiver response times and positively impact patient outcomes, while still helping facilities control waste and unnecessary costs."
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV